About TreeFRog Therapeutics

We bring together biophysicists, stem cell biologists & bioproduction engineers around the motto
"Cell Therapy for All"


TreeFrog Therapeutics was created to provide access to safe, efficient and affordable cell therapies for millions of patients.

TreeFrog TODAY

TreeFrog Therapeutics is advancing a pipeline of cell therapies with the aim of a first-in-human trial in 2024.

TreeFrog Today

Hyper-growth since incorporation in 2018

0 +
$ 0 M
raised since 2018
patent families
Advanced cell therapies
EXecutive team

Frédéric Desdouits, PhD

Chief Executive Officer
Kévin Alessandri TreeFrog Therapeutics

Kévin Alessandri, PhD

Co-Founder, Vice President U.S.

Maxime Feyeux, PhD

Co-Founder, Chief Scientific Officer
Pascale Berthet TreeFrog

Pascale Berthet, MSc

Chief Business Development officer

Michael Lanero Fidalgo, MBA

Chief Operating Officer

Fabien Moncaubeig, MSc

Chief Development Officer
Gabriel Chaigneau TreeFrog

Gabriel Chaigneau, MSc

Chief Finance officer
Marie Catoire TreeFrog

Marie Catoire, MBA

Chief People & Organization Officer
Pierre-Emmanuel Gaultier TreeFrog

Pierre-E Gaultier, MSc

Chief MARCOM Officer
Board members
Jean-Luc Treillou TreeFrog

Jean-Luc Treillou, PharmD

Chairman of the Board

Frédéric Desdouits, PhD

Kévin Alessandri TreeFrog Therapeutics

Kévin Alessandri, PhD

Co-Founder, VP USA

Guilhem de Vregille


Laurent Higueret

BPI Large Venture

Pete Zippelius

Leonard Green & Partners

Girish Pendse, PhD

Observer, BMS

Camille Le Roux Larsabal

Observer, AQUITI Gestion

Maxime Feyeux, PhD

Observer, Co-Founder, CSO TreeFrog
They trust us

Our partners

Scientific COLLABORATions
Public funding
European Commission

TreeFrog Therapeutics is receiving funding from the European Union’s Horizon 2020 research and innovation program through the SME Instrument Phase 2 under grant agreement n° SME 881113.

Logo Feder

La Région et l’Union européenne soutiennent le projet CHAMBERLAN dans le cadre du « Programme Opérationnel FEDER/FSE Aquitaine 2014-2020 » en conformité avec la règlementation européenne en matière de Fonds européens structurels et d’investissement (FESI).